Drugs / Bronchipret
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01928901 | Aug → Dec 2013 | — | Bionorica SE | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05276375 Comparator | Jan 2022 → Jun 2023 | COVID-19 | Dr. Frank Behrens | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bronchipret | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05276375 ↗ |